Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTaking Wegovy a day early is more common than you might think, and it is rarely cause for alarm. Semaglutide has a half-life of roughly a week, which means a one-day shift in timing does not produce the sharp fluctuations you would expect from a daily medicine. Your next injection should simply return to your usual scheduled day. That said, this page explains what is happening clinically and when you should speak to your prescriber. Wegovy is a prescription-only medicine, and questions about your specific dosing schedule are always best settled with the clinician overseeing your treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture it: you reach for your Wegovy pen, give the injection, then check your phone and see it is Monday — not Tuesday, the day you planned. The instinct is to worry. But the biology of semaglutide is on your side here. Unlike a tablet that peaks and clears within hours, once-weekly semaglutide builds a stable concentration in your bloodstream over several days. A one-day early dose nudges that level very slightly upward, then it settles back into the usual rhythm. The NHS medicines page for semaglutide confirms that if you take a missed or mistimed dose, you should simply continue with your normal schedule from there rather than doubling up or reshuffling permanently.
The practical rule is straightforward: note the day you actually injected, and then plan your next dose for seven days after that. If that lands close to your original weekly day, stick with the original day, a gap of six or seven days between doses is fine. What to avoid is compressing two doses into a shorter window, which does raise the risk of nausea, vomiting and other gastrointestinal effects that are already the most common experiences at dose-increase stages of treatment.
If you are newer to Wegovy and still on one of the lower steps of the titration schedule, our guide on taking Wegovy a day early and what it means for your titration progress explains why keeping the spacing consistent matters for tolerability even if the pharmacological stakes are modest.
Most people who take Wegovy a day early report nothing different at all, and if you are wondering whether you can take Wegovy a day early without it affecting your side-effect profile, the medicine's documented gastrointestinal effects (nausea, loose stools, constipation, indigestion) are most pronounced in the 24 to 72 hours after an injection, particularly after a dose increase. A one-day timing shift on a stable, established dose is unlikely to change that window meaningfully.
There are a few situations that warrant closer attention. If you are moving up to a higher strength and you took the new pen a day early, the tolerability period is slightly compressed relative to your usual routine, keep fluids up, eat smaller meals and avoid rich or fatty food in the days following. If you experience severe or persistent stomach pain that radiates towards your back, with or without vomiting, seek urgent medical help. The MHRA highlighted acute pancreatitis as an infrequent but serious consideration for GLP-1 medicines in a Drug Safety Update issued in January 2026; that warning applies regardless of dosing timing.
Allergic reactions, though rare, should also be treated urgently: swelling of the face, throat or lips, or difficulty breathing, requires a 999 call. Any side effect you want to flag formally can be reported through the MHRA Yellow Card scheme, which accepts reports directly from patients.
Once the immediate question is answered, it is worth spending a moment on why timing errors happen and how to reduce them. Many people settle on a weekly injecting day that anchors to something predictable, the same evening as a regular activity, or the morning before a standing weekly call. Our page on what happens when you take Wegovy a day early has a plain label with the date you opened the pack; some people photograph that label as a simple reminder.
If you are considering whether your current Wegovy schedule, dose, or access route is still the right fit, that is exactly the kind of question a prescriber can work through with you. For broader context on how semaglutide works and what the treatment journey typically involves, the Wegovy overview at nume covers the full picture. If cost or practicalities are part of what you are thinking about, the Wegovy cost page sets out what is included in a private prescription route transparently.
One thing worth knowing: every repeat order through a regulated online pharmacy should involve a clinical review before the next pen is dispatched. At nume, a GPhC-registered prescriber reads your consultation before approval, not a checklist, not software. If timing errors or side effects are part of your experience, that review is the place to raise them. You can also reach the aftercare team directly, seven days a week.
If you have wider questions about semaglutide or weight management treatment options, our weight-loss treatments overview is a useful starting point, and if you are still unsure whether taking Wegovy just 1 day early is something your schedule can accommodate, the FAQs page covers many of the practical questions that come up during treatment.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.